These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24726807)

  • 41. Posaconazole, a Second-Generation Triazole Antifungal Drug, Inhibits the Hedgehog Signaling Pathway and Progression of Basal Cell Carcinoma.
    Chen B; Trang V; Lee A; Williams NS; Wilson AN; Epstein EH; Tang JY; Kim J
    Mol Cancer Ther; 2016 May; 15(5):866-76. PubMed ID: 26823493
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design, synthesis, and biological evaluation of structurally modified isoindolinone and quinazolinone derivatives as hedgehog pathway inhibitors.
    Bhattarai D; Jung JH; Han S; Lee H; Oh SJ; Ko HW; Lee K
    Eur J Med Chem; 2017 Jan; 125():1036-1050. PubMed ID: 27810591
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer.
    Brechbiel J; Miller-Moslin K; Adjei AA
    Cancer Treat Rev; 2014 Jul; 40(6):750-9. PubMed ID: 24613036
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exploring the Potential of Anthraquinone-Based Hybrids for Identifying a Novel Generation of Antagonists for the Smoothened Receptor in HH-Dependent Tumour.
    Quaglio D; Infante P; Cammarone S; Lamelza L; Conenna M; Ghirga F; Adabbo G; Pisano L; Di Marcotullio L; Botta B; Mori M
    Chemistry; 2023 Nov; 29(62):e202302237. PubMed ID: 37565343
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolites in vertebrate Hedgehog signaling.
    Roberg-Larsen H; Strand MF; Krauss S; Wilson SR
    Biochem Biophys Res Commun; 2014 Apr; 446(3):669-74. PubMed ID: 24486313
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Strategies to target the Hedgehog signaling pathway for cancer therapy.
    Xin M; Ji X; De La Cruz LK; Thareja S; Wang B
    Med Res Rev; 2018 May; 38(3):870-913. PubMed ID: 29315702
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence for allosteric interactions of antagonist binding to the smoothened receptor.
    Rominger CM; Bee WL; Copeland RA; Davenport EA; Gilmartin A; Gontarek R; Hornberger KR; Kallal LA; Lai Z; Lawrie K; Lu Q; McMillan L; Truong M; Tummino PJ; Turunen B; Will M; Zuercher WJ; Rominger DH
    J Pharmacol Exp Ther; 2009 Jun; 329(3):995-1005. PubMed ID: 19304771
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Smoothened inhibition leads to decreased proliferation and induces apoptosis in esophageal adenocarcinoma cells.
    Zaidi AH; Komatsu Y; Kelly LA; Malhotra U; Rotoloni C; Kosovec JE; Zahoor H; Makielski R; Bhatt A; Hoppo T; Jobe BA
    Cancer Invest; 2013 Aug; 31(7):480-9. PubMed ID: 23915072
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular Modelling of Berberine Derivatives as Inhibitors of Human Smoothened Receptor and Hedgehog Signalling Pathway Using a Newly Developed Algorithm on Anti-Cancer Drugs.
    Kaboli PJ; Bazrafkan M; Ismail P; Ling KH
    Recent Pat Anticancer Drug Discov; 2017 Nov; 12(4):384-400. PubMed ID: 28969581
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting the hedgehog signaling pathway with small molecules.
    Kiselyov AS
    Anticancer Agents Med Chem; 2006 Sep; 6(5):445-9. PubMed ID: 17017853
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design of Hedgehog pathway inhibitors for cancer treatment.
    Bariwal J; Kumar V; Dong Y; Mahato RI
    Med Res Rev; 2019 May; 39(3):1137-1204. PubMed ID: 30484872
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blocking smoothened cholesterylation: A strategy for overcoming drug resistance in cancer.
    Cheng SY; Zhang YE
    Cell Chem Biol; 2024 Jul; 31(7):1231-1233. PubMed ID: 39029450
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discovery and characterization of a potent Wnt and hedgehog signaling pathways dual inhibitor.
    Ma H; Chen Q; Zhu F; Zheng J; Li J; Zhang H; Chen S; Xing H; Luo L; Zheng LT; He S; Zhang X
    Eur J Med Chem; 2018 Apr; 149():110-121. PubMed ID: 29499483
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hedgehog Signaling: From Basic Biology to Cancer Therapy.
    Wu F; Zhang Y; Sun B; McMahon AP; Wang Y
    Cell Chem Biol; 2017 Mar; 24(3):252-280. PubMed ID: 28286127
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hedgehog signaling pathway regulates human pancreatic cancer cell proliferation and metastasis.
    Hao K; Tian XD; Qin CF; Xie XH; Yang YM
    Oncol Rep; 2013 Mar; 29(3):1124-32. PubMed ID: 23292285
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of a novel Smoothened antagonist that potently suppresses Hedgehog signaling.
    Wang J; Mook RA; Lu J; Gooden DM; Ribeiro A; Guo A; Barak LS; Lyerly HK; Chen W
    Bioorg Med Chem; 2012 Nov; 20(22):6751-7. PubMed ID: 23063522
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glucocorticoid compounds modify smoothened localization and hedgehog pathway activity.
    Wang Y; Davidow L; Arvanites AC; Blanchard J; Lam K; Xu K; Oza V; Yoo JW; Ng JM; Curran T; Rubin LL; McMahon AP
    Chem Biol; 2012 Aug; 19(8):972-82. PubMed ID: 22921064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting the Hedgehog signaling pathway in cancer: beyond Smoothened.
    Gonnissen A; Isebaert S; Haustermans K
    Oncotarget; 2015 Jun; 6(16):13899-913. PubMed ID: 26053182
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery of Hedgehog Antagonists for Cancer Therapy.
    Khatra H; Bose C; Sinha S
    Curr Med Chem; 2017; 24(19):2033-2058. PubMed ID: 28302010
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A molecular dynamics approach to identify an oxysterol-based hedgehog pathway inhibitor.
    Dash RC; Maschinot CR; Hadden MK
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):168-177. PubMed ID: 27825830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.